I-Tech AB (ITECH.ST)

SEK 54.5

(-1.8%)

Eps Summary of I-Tech AB

  • I-Tech AB's latest annual eps in 2023 was 1.70 SEK , up 91.01% from previous year.
  • I-Tech AB's latest quarterly eps in 2024 Q3 was 0.70 SEK , down -10.96% from previous quarter.
  • I-Tech AB reported an annual eps of 0.89 SEK in 2022, up 504.55% from previous year.
  • I-Tech AB reported an annual eps of -0.22 SEK in 2021, up 45.0% from previous year.
  • I-Tech AB reported a quarterly eps of 0.70 SEK for 2024 Q3, down -10.96% from previous quarter.
  • I-Tech AB reported a quarterly eps of 0.69 SEK for 2024 Q1, up 2304.47% from previous quarter.

Annual Eps Chart of I-Tech AB (2023 - 2015)

Historical Annual Eps of I-Tech AB (2023 - 2015)

Year Eps Eps Growth
2023 1.70 SEK 91.01%
2022 0.89 SEK 504.55%
2021 -0.22 SEK 45.0%
2020 -0.40 SEK -156.34%
2019 0.71 SEK 161.74%
2018 -1.15 SEK -61.97%
2017 -0.71 SEK -18.33%
2016 -0.60 SEK 79.73%
2015 -2.96 SEK 0.0%

Peer Eps Comparison of I-Tech AB

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 409.091%
Ziccum AB (publ) -1.54 SEK 210.39%
Modus Therapeutics Holding AB (publ) -1.01 SEK 268.317%
BioArctic AB (publ) 2.60 SEK 34.615%
Sprint Bioscience AB (publ) -0.01 SEK 27084.127%
Mendus AB (publ) -4.40 SEK 138.636%
Genovis AB (publ.) 0.94 SEK -80.851%
Intervacc AB (publ) -1.69 SEK 200.592%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 872.727%
Active Biotech AB (publ) -0.17 SEK 1100.0%
Magle Chemoswed Holding AB (publ) 1.13 SEK -50.442%
Bio-Works Technologies AB (publ) -1.57 SEK 208.28%
Aptahem AB (publ) -0.05 SEK 3619.669%
Vicore Pharma Holding AB (publ) -3.22 SEK 152.795%
Kancera AB (publ) -0.80 SEK 312.5%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 117.085%
Fluicell AB (publ) -0.24 SEK 808.333%
Saniona AB (publ) -1.29 SEK 231.783%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 994.737%
Biovica International AB (publ) -2.14 SEK 179.439%
Spago Nanomedical AB (publ) -0.43 SEK 495.349%
AcouSort AB (publ) -1.29 SEK 231.783%
Xintela AB (publ) -0.13 SEK 1407.692%
Abliva AB (publ) -0.09 SEK 1980.531%
Egetis Therapeutics AB (publ) -1.27 SEK 233.858%
Karolinska Development AB (publ) 0.02 SEK -8400.0%
OncoZenge AB (publ) -1.36 SEK 225.0%
Amniotics AB (publ) -0.01 SEK 15554.545%
2cureX AB (publ) -1.85 SEK 191.892%
CombiGene AB (publ) -1.80 SEK 194.444%
Asarina Pharma AB (publ) -0.57 SEK 398.246%
Calliditas Therapeutics AB (publ) -8.69 SEK 119.563%
Camurus AB (publ) 7.78 SEK 78.149%
Corline Biomedical AB -0.08 SEK 2119.002%
IRLAB Therapeutics AB (publ) -3.43 SEK 149.563%
Isofol Medical AB (publ) -0.23 SEK 839.13%
Hansa Biopharma AB (publ) -15.83 SEK 110.739%
Cyxone AB (publ) -0.22 SEK 872.727%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 185.859%
Biosergen AB -0.60 SEK 383.333%
Cantargia AB (publ) -1.65 SEK 203.03%
NextCell Pharma AB -1.03 SEK 265.049%
Xspray Pharma AB (publ) -6.76 SEK 125.148%
Elicera Therapeutics AB (publ) -0.83 SEK 304.819%
Nanologica AB (publ) -2.05 SEK 182.927%
SynAct Pharma AB -6.64 SEK 125.602%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 753.846%
Stayble Therapeutics AB (publ) -0.92 SEK 284.783%
LIDDS AB (publ) -0.63 SEK 369.841%
Lipum AB (publ) -4.45 SEK 138.202%
BioInvent International AB (publ) -5.02 SEK 133.865%
Alzinova AB (publ) -0.41 SEK 514.634%
Oncopeptides AB (publ) -1.96 SEK 186.735%
Pila Pharma AB (publ) -0.47 SEK 461.702%
Guard Therapeutics International AB (publ) -11.26 SEK 115.098%
Scandinavian ChemoTech AB (publ) -1.13 SEK 250.442%
Simris Alg AB (publ) -0.16 SEK 1162.5%
Diamyd Medical AB (publ) -1.60 SEK 206.25%
Xbrane Biopharma AB (publ) -1.27 SEK 233.858%
Ascelia Pharma AB (publ) -3.24 SEK 152.469%
Diagonal Bio AB (publ) -0.32 SEK 631.25%